Dr. Robert Hancock`s Peptide Work May Lead to New Treatment Approach to Malaria
Anti-inflammatory agents developed by NGDI Co-Founder Robert Hancock, used in combination with anti-malarial drugs, have been shown to boost survival rates of severe malaria.
2012 AAPS Pharmaceuticals in Global Health Student Travelships
NGDI-UBC is pleased to offer travelships for eligible students presenting papers at the 2012 AAPS Annual Meeting and Exposition.
NGDI-UBC article in the International Pharmacy Journal
An article on NGDI and the work it has been doing at UBC was published in the International Pharmacy Journal.
Update on NGDI – CDRD Partnership: One year later
Fight Against Neglected Global Diseases Moves Another Step Forward Through a Partnership Between CDRD and NGDI-UBC.
NGDI associate member receives Grand Challenges grant
Congratulations to NGDI associate member Richard Lester who received a $100,000 grant for his project WelTel through Grand Challenges Canada.
NGDI and SBN Celebrate Research Week
NGDI and The Science Biotechnology Network presents a seminar and poster event in light of Celebrate Research Week.
NGDI Distinguished Lectureship Seminar: Dr. Keith Martin
Please come and hear Dr. Keith Martin speak about the work he is doing to bridge the knowledge-action gap in global health at NGDI’s fifth Distinguished Lectureship Seminar.
Uniting to Combat Neglected Tropical Diseases
Partners pledge innovative, coordinated action aimed at new World Health Organisation goals
NGDI Associate David Grierson receives $400,000 CIHR Grant for HIV Work
The project explores a new Anti-HIV/AIDS strategy regarding small molecule inhibitors.
NGDI-UBC Annual Report 2011
The NGDI Annual Report has been released. To view the report, please download here.